CDC-RFA-GH22-2252: Strengthening Sample Transportation System in Malawi under the President's Emergency Plan for AIDS Relief (PEPFAR)
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Centers for Disease Control - CGH notices from 2021.
Centers for Disease Control - CGH offered grants to any type of organization. It expected to make about 2 awards. Applications closed on February 28, 2022.
From the official notice on Grants.gov, last changed February 3, 2022. Checked November 7, 2026.
- Expected awards2
- Award amountsNot given on Grants.gov
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | December 30, 2021 |
|---|---|
| Deadline | February 28, 2022 |
| Archived by Grants.gov | March 28, 2022 |
Who can apply
This opportunity was open to any type of organization.
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Is this a realistic fit?
- Most of the program's money (62% over five years) went to nonprofits.
- No cost sharing or match is required.
What the grant funds
The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $1,800,000 for Year 1, subject to the availability of funds. The NOFO will strengthen the existing local sample transportation system. The current partial integrated sample transportation system covers samples for Human immunodeficiency virus (HIV) viral load (VL), Early Infant Diagnosis (EID), Tuberculosis (TB) Hepatitis and Cervical Cancer in all 28 districts in Malawi. The sample transportation program needs to expand in coverage and frequency of visits to health facilities due to expansion in Pre-exposure prophylaxis (PrEP) and plasma HIV VL sample testing. Therefore, through this NOFO the recipient will: Strengthen the national sample transportation system as an independent program Build government capacity and promote sustainability and ownership Work directly with Ministry of Health (MOH) and other stakeholders Implement pulling system to improve efficiency and sample integrity
Who has won Global AIDS grants before
From fiscal 2021 to 2025, Global AIDS (93.067) awarded $7.6 billion across 521 grant awards, an average of $14.6 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| The Trustees of Columbia University in the City of New York | New York | 32 | $684 million |
| Elizabeth Glaser Pediatric AIDS Foundation | District of Columbia | 13 | $387 million |
| Management and Development for Health | 5 | $282 million | |
| Apin Public Health Initiatives LTD/Gte | 4 | $209 million | |
| University of Washington | Washington | 8 | $195 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is CDC-RFA-GH22-2252 still open?
No. It closed on February 28, 2022.
Who can apply for Strengthening Sample Transportation System in Malawi under the President's Emergency Plan for AIDS Relief (PEPFAR)?
Centers for Disease Control - CGH accepted applications from any type of organization.
What is the deadline for Strengthening Sample Transportation System in Malawi under the President's Emergency Plan for AIDS Relief (PEPFAR)?
Closed February 28, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.
Who has won Global AIDS grants before?
The largest recipients over five fiscal years were The Trustees of Columbia University in the City of New York, Elizabeth Glaser Pediatric AIDS Foundation, Management and Development for Health. The program made 521 awards worth $7.6 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)